{"id":23575,"date":"2023-04-18T09:28:07","date_gmt":"2023-04-18T07:28:07","guid":{"rendered":"https:\/\/idibell.cat\/?p=23575"},"modified":"2023-08-01T18:35:56","modified_gmt":"2023-08-01T16:35:56","slug":"la-generalitat-reconeix-32-grups-de-lidibell-com-a-grups-de-recerca-consolidats-o-emergents","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2023\/04\/la-generalitat-reconeix-32-grups-de-lidibell-com-a-grups-de-recerca-consolidats-o-emergents\/","title":{"rendered":"La Generalitat reconeix 32 grups de l\u2019IDIBELL com a Grups de Recerca Consolidats o Emergents"},"content":{"rendered":"
L’objectiu de la convocat\u00f2ria \u00e9s impulsar les activitats dels grups de recerca que permetin refor\u00e7ar l’impacte cient\u00edfic, econ\u00f2mic i social de la investigaci\u00f3, aix\u00ed com promoure’n la projecci\u00f3 internacional. La convocat\u00f2ria preveu el reconeixement dels grups de recerca que compleixin els requisits per a cada modalitat i, en alguns casos, l\u2019atorgament de finan\u00e7ament en funci\u00f3 de la puntuaci\u00f3 obtinguda.<\/p>\n
En el cas de l\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), l\u2019Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca (AGAUR) de la Generalitat de Catalunya ha concedit 29 acreditacions de Grup de Recerca Consolidat i 3 de Grup de Recerca Emergent. A m\u00e9s, d\u2019aquests, 19 grups rebran finan\u00e7ament per un total de 901.694,38 euros.<\/p>\n
<\/p>\n
Llistat de grups acreditats:<\/strong><\/p>\n <\/p>\n Gr\u00e0cies al suport de:<\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" L\u2019Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca (AGAUR) ha publicat aquesta setmana la resoluci\u00f3 definitiva de la convocat\u00f2ria dels ajuts per donar suport a les activitats dels grups de recerca d\u2019universitats, centres i fundacions. En la convocat\u00f2ria d\u2019enguany ha reconegut com a Grups de Recerca Consolidats o Emergents a 32 grups de l\u2019IDIBELL, dels quals 19 rebran finan\u00e7ament.<\/p>\n","protected":false},"author":8,"featured_media":23577,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,427],"tags":[],"class_list":["post-23575","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","category-malalties-sistemiques-i-envelliment"],"publishpress_future_action":{"enabled":false,"date":"2025-01-29 04:51:17","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=23575"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23575\/revisions"}],"predecessor-version":[{"id":24098,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23575\/revisions\/24098"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/23577"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=23575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=23575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=23575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\n
\n Nom del grup<\/strong><\/td>\n Investigador\/a principal<\/strong><\/td>\n<\/tr>\n \n Epidemiologia Molecular i Gen\u00e8tica en Infeccions i C\u00e0ncer<\/td>\n Laia Alemany Vilches<\/td>\n<\/tr>\n \n Modelatge del c\u00e0ncer i terap\u00e8utica experimental<\/td>\n Ramon Alemany Bonastre<\/td>\n<\/tr>\n \n Recerca en serveis sanitaris en c\u00e0ncer<\/td>\n Josep Maria Borras Andres<\/td>\n<\/tr>\n \n Informaci\u00f3 i Intervencions en Infeccions i C\u00e0ncer<\/td>\n Laia Bruni Coccoz<\/td>\n<\/tr>\n \n Interacci\u00f3 Tumor Estroma i Resist\u00e8ncia Terap\u00e8utica<\/td>\n Oriol Casanovas Casanovas<\/td>\n<\/tr>\n \n Bioheart: Grup de Malalties Cardiovasculars<\/td>\n Josep Comin Colet<\/td>\n<\/tr>\n \n Paper del TGF-beta i de l’estr\u00e8s oxidatiu en patologies humanes<\/td>\n Maria Isabel Fabregat Romero<\/td>\n<\/tr>\n \n Epidemiologia, Prevenci\u00f3 i Control del Tabaquisme<\/td>\n Esteve Fernandez Mu\u00f1oz<\/td>\n<\/tr>\n \n Psiconeurobiologia de l’alimentaci\u00f3 i les conductes addictives<\/td>\n Fernando Fernandez Aranda<\/td>\n<\/tr>\n \n Medicina Regenerativa<\/td>\n Maria Carolina Florian<\/td>\n<\/tr>\n \n Infermera (GRIN-IDIBELL)<\/td>\n Maria Eul\u00e0lia Juv\u00e9 Udina<\/td>\n<\/tr>\n \n C\u00e0ncer Hereditari<\/td>\n Conxi L\u00e1zaro Garcia<\/td>\n<\/tr>\n \n Noves ter\u00e0pies per al tractament de c\u00e0ncer de pell<\/td>\n Purificacion Mu\u00f1oz Moruno<\/td>\n<\/tr>\n \n Psicooncologia i Salut Digital<\/td>\n Cristian Ochoa Arnedo<\/td>\n<\/tr>\n \n Malalties Neurometab\u00f2liques<\/td>\n Aurora Pujol Onofre<\/td>\n<\/tr>\n \n Aplicacions biom\u00e8diques de la tecnologia cel\u00b7lular iPS<\/td>\n Angel Raya Chamorro<\/td>\n<\/tr>\n \n Biologia de l’ARN en el desenvolupament del tumor<\/td>\n Barbara Rivera Polo<\/td>\n<\/tr>\n \n Ribo-Colon<\/td>\n Ramon Salazar Soler<\/td>\n<\/tr>\n \n Gen\u00e8tica, ter\u00e0pia i resist\u00e8ncia en tumors epitelials igerminals<\/td>\n Francesc Vi\u00f1als Canals<\/td>\n<\/tr>\n \n Nutrici\u00f3 i C\u00e0ncer<\/td>\n Antonio Agudo Trigueros<\/td>\n<\/tr>\n \n Risc Vascular del Consorci Sanitari Integral<\/td>\n Pedro Armario Garcia<\/td>\n<\/tr>\n \n Nefrologia i Trasplantament Renal (Nefrobell)<\/td>\n Josep Maria Cruzado Garrit<\/td>\n<\/tr>\n \n Cures Pal\u00b7liatives (GRICOPAL)<\/td>\n Jesus Gonzalez Barboteo<\/td>\n<\/tr>\n \n Radiobiologia i C\u00e0ncer<\/td>\n Ferran Guedea i Edo<\/td>\n<\/tr>\n \n Sarcomes<\/td>\n Oscar Martinez Tirado<\/td>\n<\/tr>\n \n Psiquiatria Cl\u00ednico-Biol\u00f2gica i Psicologia<\/td>\n Jose Manuel Menchon Magri\u00f1a<\/td>\n<\/tr>\n \n Diabetis i Metabolisme<\/td>\n Eduard Montanya Mias<\/td>\n<\/tr>\n \n Prevenci\u00f3 del C\u00e0ncer<\/td>\n Victor Moreno Aguado<\/td>\n<\/tr>\n \n Recerca precl\u00ednica i experimental dels tumors tor\u00e0cics<\/td>\n Cristina Mu\u00f1oz Pinedo<\/td>\n<\/tr>\n \n Gens, Malaltia i Ter\u00e0pia<\/td>\n Virginia Nunes Mart\u00ednez<\/td>\n<\/tr>\n \n Malalties Sist\u00e8miques i Envelliment<\/td>\n Antoni Riera Mestre<\/td>\n<\/tr>\n \n Resist\u00e8ncia terap\u00e8utica en neopl\u00e0sies hematol\u00f2giques<\/td>\n Ana Maria Sureda Balari<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n